Browsing: Expert columns

vials-in-sampler
0

In this instalment of Robert MacNeill’s column, he explores hydrophilic-interaction liquid chromatography (HILIC) and how the technique is often overlooked.

coronavirus 3
0

As the COVID-19 pandemic extends its reach worldwide, the demand for available, accurate testing is growing exponentially. Science News reports that COVID-19 testing has been available in limited quantities from the Centers for Disease Control (CDC), but production has not been able to keep up with demand.

Single cell proteomics rev
0

This exclusive editorial explores the very recent and very exciting developments in the field of single cell proteomics. Is now the time to realize the potential of SCoPE-MS?

clear-solution-in-vial
0

In this installment of Robert MacNeill’s (Covance) column, Robert discusses the potential disparity in results when using a given method for extracted analytical batches versus in solution, the different challenges involved with solutions and extracts and the necessity to fully consider the relevant chemistry from the earliest stages of method development.

Brexit BZ
0

Brexit or no Brexit? The question that has been weighing on the UK for the past 3 years will soon have an answer (hopefully). Read this commentary from Zamas Lam (QPS; DE, USA) discussing how Brexit relates to the future of drug discovery, preclinical and clinical drug development.

Brexit BZ
0

With the reality of Brexit already impacting the UK’s clinical trials environment, Zamas Lam (QPS; DE, USA) discusses the effect this will have on bioanalytical research, and suggests 10 questions to ask when relocating UK-based preclinical and bioanalysis research projects.

1 2 3